. Author manuscript; available in PMC: 2017 Feb 1.

Published in final edited form as: Cancer Prev Res (Phila). 2015 Dec 23;9(2):159–171. doi: 10.1158/1940-6207.CAPR-15-0187

Table 3.

Fold differences in expression for prognostic molecular biomarkers of oral carcinogenesis and BRB predicative molecular biomarkers in OSCC patients.

	Prognostic Molecular Biomarkers				Predictive Molecular Biomarkers
	OSCC1 – HARM1				OSCC2 – OSCC1
	Fold-Change	CI			Fold-Change	CI
AURKA	+4.47	+2.62	+7.64	^a,^b	−3.12	−5.45	−1.78	^a,^b
BAX	+2.48	+1.66	+3.70	^a,^b	−0.94	−2.02	+2.28	^a
BCL2	+1.01	−1.45	+1.49		−1.84	−2.90	−1.17
BIRC5	+3.92	+2.48	+6.18	^a	−2.60	−3.71	−1.83	^a,^b
CASP3	+1.91	−1.26	+4.58		−6.15	−18.79	−2.01	^a
CASP14	+1.73	−1.63	+4.88		−1.96	−3.93	+1.02
EGFR	+2.33	+1.33	+4.07	^a	−2.60	−3.79	−1.67	^a,^b
NFKB1	+2.68	+1.68	+4.27	^a,^b	−3.76	−6.14	−2.30	^a,^b
PTGS1	+3.41	+2.24	+5.20	^a,^b	−4.14	−7.41	−2.32	^a,^b
PTGS2	+20.97	+13.44	+32.71	^a,^b	−2.87	−6.52	−1.26	^a
TBXA2R	+5.74	+3.32	+9.91	^a,^b	−1.43	−3.11	+1.51

BRB effect is >2 s.e.m.

BRB effect is > Bonferroni bound CI, upper and lower limits for 90% confidence interval